Wintac gets nod for slump sale of pharmaceutical business undertaking

27 Apr 2018 Evaluate

Wintac’s board has approved the proposal to effect slump sale of the Pharmaceutical Business Undertaking of the company to Par Formulations. The board of directors of the company at their meeting held on April 26, 2018, considered and approved the same.

Besides, the Board approved the business transfer agreement to be entered into with Par Formulations.

Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.

Wintac Share Price

341.60 0.00 (0.00%)
17-Dec-2020 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.